Mark P. Marriott
300 Grattan Street
Melbourne, VIC, Australia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2.
Journal: The Medical journal of Australia
Published: October 09, 2024
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 26, 2024
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1.
Journal: The Medical journal of Australia
Published: April 25, 2024
Neutropaenia complications from Ocrelizumab and Rituximab treatment.
Journal: Multiple sclerosis and related disorders
Published: January 30, 2023
Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic.
Journal: Multiple sclerosis and related disorders
Published: February 10, 2022
Failure of alemtuzumab therapy in three patients with MOG antibody associated disease.
Journal: BMC neurology
Published: November 14, 2021
Response to treatment in NMOSD: the Australasian experience.
Journal: Multiple sclerosis and related disorders
Published: September 30, 2021
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
Journal: Multiple sclerosis and related disorders
Published: July 16, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Journal: Frontiers in neurology
Published: March 12, 2020
The clinical profile of NMOSD in Australia and New Zealand.
Journal: Journal of neurology
Published: November 05, 2019
Last Updated: 09/26/2026